Company
Exponential Biotherapies
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
develops therapeutics to attenuate overreactions of the immune system that may lead to severe organ damage and death. The company’s lead product targets acute renal failure following surgery, an important cause of death in hospital intensive care units.
Loading relationship preview